Patterson Companies, Inc.
Patterson Companies, Inc. (PDCO) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
pdco · pe ratio · data through Apr 27, 2024
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Patterson Companies, Inc. (PDCO) measures how much investors pay for each dollar of the company's trailing earnings. PDCO's current PE ratio of 15.67x is calculated by dividing its stock price of $31.33 by its TTM earnings per share of $2.00. −8.0% discount vs 5Y avg 17.0x
Source: FMP · /ratios-ttm · /analyst-estimates · 2024-04-27
PE Ratio History
2005 – 2024 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 19 fiscal years · Front-end computedMinQ1 · 25%19.7x
MedianQ3 · 75%37.7x
Max
At 15.67x, PDCO's current P/E is within its average historical range over the past 19 fiscal years.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Distribution · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Patterson Companies, Inc.You PDCO | $2.8B | 15.67x | — | $2.00 |
 Amedisys, Inc. AMED | $3.3B | 68.71x | — | $1.32 |
 Chinook Therapeutics, Inc. KDNY | $2.7B | N/A | — | -$2.87 |
 Longboard Pharmaceuticals, Inc. LBPH | $2.3B | N/A | — | -$2.39 |
 MorphoSys AG MOR | $2.9B | N/A | — | -$1.38 |
 Morphic Holding, Inc. MORF | $2.9B | N/A | — | -$3.59 |
 Myovant Sciences Ltd. MYOV | $2.6B | N/A | — | -$2.22 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2024-04-27Latest FY2024 | 12.89x | $2.00 | +1.7% | |
2023-04-29 FY2023 | 12.67x | $2.14 | -14.0% | |
2022-04-30 FY2022 | 14.73x | $2.09 | -28.2% | |
2021-04-24 FY2021 | 20.51x | $1.63 | — | |
2020-04-25 FY2020 | — | $-6.26 | — | |
2019-04-27 FY2019 | 24.29x | $0.90 | +122.2% | |
2018-04-28 FY2018 | 10.93x | $2.17 | -55.8% | |
2017-04-29 FY2017 | 24.71x | $1.80 | +9.7% | |
2016-04-30 FY2016 | 22.52x | $1.93 | +5.4% | |
2015-04-25 FY2015 | 21.37x | $2.26 | +4.0% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Patterson Companies, Inc. (PDCO) measures how much investors pay for each dollar of the company's trailing earnings. PDCO's current PE ratio of 15.67x is calculated by dividing its stock price of $31.33 by its TTM earnings per share of $2.00.
Frequently asked questions
PDCO pe ratio · 6 questionsPDCO's current PE ratio is 15.67x as of 2026-06-08, based on a stock price of $31.33 and TTM EPS of $2.00. Data sourced from Financial Modeling Prep via PDCO's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Patterson Companies, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08